Globally, 296 million people are infected with hepatitis B virus (HBV), and approximately one
million people die annually from HBV-related causes, including liver cancer. Although there …

MicroRNAs (miRNAs) are fundamental post-transcriptional modulators of several critical
cellular processes, a number of which are involved in host defense mechanisms. In …

This document presents official recommendations of the American Association for the Study
of Liver Diseases (AASLD) on the surveillance, diagnosis, and treatment of hepatocellular …

Alcohol-related liver disease is the most prevalent type of chronic liver disease worldwide,
accounting for 30% of hepatocellular carcinoma (HCC) cases and HCC-specific deaths …

Background: The GALAD score is a serum biomarker–based model that predicts the
probability of having hepatocellular carcinoma (HCC) in patients with chronic liver disease …

Abstract Alpha-fetoprotein (AFP), Lens culinaris-agglutinin-reactive fraction of AFP (AFP-L3),
and protein induced by vitamin K absence or antagonist-II (PIVKA-II) are widely used as …

Oncology indispensably leads us to personalized medicine, which allows an individual
approach to be taken with each patient. Personalized oncology is based on …

Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality
worldwide. Delayed diagnosis is a major factor responsible for the poor prognosis of HCC …

Chronic hepatitis B is one of the leading causes of hepatocellular carcinoma (HCC)
worldwide. Accurate prediction of HCC risk is important for decisions on antiviral therapy …

Growing evidence suggests that pretransplant alpha‐fetoprotein (AFP) predicts outcomes of
hepatocellular carcinoma (HCC) patients treated with liver transplantation. We aimed to …